Fibrosing Cholestatic Hepatitis After Methotrexate and Prednisone Therapy for Rheumatoid Arthritis

TOPALOĞLU, SERDAR; ÇALIK, ADNAN; KALAYCI, Orhan; Cesmecioglu, EMİNE; ÇOBANOĞLU, ÜMİT; UZUN, Yusuf

doi:10.6002/ect.25liver.p7

Fibrosing Cholestatic Hepatitis After Methotrexate and Prednisone Therapy for Rheumatoid Arthritis

Copy For Citation

TOPALOĞLU S., ÇALIK A., KALAYCI O., Cesmecioglu E., ÇOBANOĞLU Ü., UZUN Y.

EXPERIMENTAL AND CLINICAL TRANSPLANTATION, vol.12, pp.95-97, 2014 (SCI-Expanded)

Publication Type: Article / Article
Volume: 12
Publication Date: 2014
Doi Number: 10.6002/ect.25liver.p7
Journal Name: EXPERIMENTAL AND CLINICAL TRANSPLANTATION
Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Page Numbers: pp.95-97
Keywords: Fibrosing cholestatic hepatitis, Hepatotoxicity, Methotrexate, Fulminant liver failure, Liver transplant, HEPATOTOXICITY, LIVER
Karadeniz Technical University Affiliated: Yes

Abstract

Objectives: Fibrosing cholestatic hepatitis is an aggressive and usually fatal form of viral hepatitis in immunosuppressed patients. We assessed the hepatotoxicity of methotrexate and prednisolone combination therapy in the background of hepatitis B virus infection.